Cardiac arrest research in humans has failed to fulfil expectations ge
nerated by laboratory studies. This reflects a number of factors. It i
s difficult to perform clinical research in the setting of emergency c
ardiac resuscitation. Both the epidemiology and pathophysiology of sud
den death present special problems to the clinical researcher. Laborat
ory studies and clinical trials have failed to faithfully mimic each o
ther. Estimation of sample size and application of inclusion/exclusion
criteria present special problems in methodology. Our focus on improv
ing long term survival by changing one component of therapy may have b
een premature and obscured the utility of extant data. Many of these p
roblems can be addressed through refinements in: laboratory models, ou
r understanding of the underlying pathophysiology, estimation of sampl
e size, the application of inclusion/exclusion criteria, the identific
ation of the primary dependent variables and subgroups of interest, th
e overall quality of therapy. Clinical studies will not generate usefu
l data until these issues, among others, have been addressed.